Synergistic therapeutic strategies and engineered nanoparticles for anti-vascular endothelial growth factor therapy...

Area of Science:

• Oncology
• Biotechnology
• Pharmacology

Background:

• Angiogenesis, driven by vascular endothelial growth factor (VEGF), is a hallmark of cancer.
• Antiangiogenic therapies are increasingly used in cancer treatment but can lead to resistance and poor outcomes.
• Refining combination strategies and targeted treatments are crucial for improving efficacy.

Purpose of the Study:

• To review novel synergistic therapeutic strategies for cancer treatment.
• To explore the potential of nanomedicine in antiangiogenic therapy.
• To address limitations of current antiangiogenic approaches.

Main Methods:

• Review of current literature on antiangiogenic therapies, combination strategies, nanomedicine, and gene therapy.
• Analysis of nanoparticle capabilities in drug delivery and overcoming resistance.
• Focus on synergistic therapeutic approaches targeting angiogenesis.

Main Results:

• Antiangiogenic therapy faces challenges including resistance, invasion, and limited survival.
• Nanoparticles offer potential solutions for selectivity, targeted delivery, and overcoming multi-drug resistance.
• Synergistic strategies combining antiangiogenic agents with cytotoxic treatments show promise.

Conclusions:

• Novel synergistic therapeutic strategies, particularly those integrating nanomedicine, present a promising alternative for cancer treatment.
• Targeted nanoparticles can enhance the efficacy of antiangiogenic therapy by improving drug delivery and overcoming resistance.
• Further research into these advanced strategies is essential for developing more effective cancer treatments.